NCT07909369 Medial Unloader Brace After Root Repair
| NCT ID | NCT07909369 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Arthroscopic Medial Meniscus Posterior Root Repair |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2026-10-19 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2026-10-19 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate whether medial unloader bracing improves healing and clinical outcomes following arthroscopic medial meniscus posterior root repair. The primary aim is to compare 5-month MRI-based healing rates, meniscal extrusion, and cartilage changes between patients who use a medial unloader brace and those who do not following medial meniscus posterior root repair.
Eligibility Criteria
Inclusion Criteria: 1. Age 18-60 years at the time of enrollment. 2. Undergoing arthroscopic medial meniscus posterior root repair performed by a study investigator. 3. Willingness and ability to comply with postoperative rehabilitation protocols and study follow-up visits. 4. Willingness and ability to undergo postoperative MRI imaging as part of routine follow-up. 5. Ability to understand the study procedures and provide informed consent. 6. Ambulatory prior to surgery and expected to resume weightbearing as part of standard postoperative care. 7. Medically appropriate candidate for use of a medial unloader valgus knee brace, as determined by the treating surgeon. Exclusion Criteria: 1. Age less than 18 or greater than 60 years. 2. Inability or unwillingness to provide informed consent. 3. Prior surgery on the ipsilateral knee that would interfere with assessment of meniscal healing or extrusion. 4. Concomitant ligamentous injury requiring reconstruction at the time of meniscal root repair (e.g., anterior cruciate ligament (ACL) or Posterior Cruciate Ligament (PCL) reconstruction). 5. Advanced medial compartment osteoarthritis, defined as Kellgren-Lawrence grade 4. 6. Contraindication to MRI imaging (e.g., non-MRI compatible implants, severe claustrophobia). 7. Known allergy or intolerance to materials used in medial unloader valgus knee braces. 8. Neurologic, musculoskeletal, or medical conditions that would preclude safe brace use or interfere with gait mechanics. 9. Inability to comply with postoperative rehabilitation or study follow-up requirements, in the opinion of the investigator. 10. Pregnancy at the time of enrollment (not eligible for surgery).
Contact & Investigator
Eric Strauss
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT07909369 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Arthroscopic Medial Meniscus Posterior Root Repair. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07909369 currently recruiting?
Yes, NCT07909369 is actively recruiting participants. Contact the research team at Nicole.oberlag@nyulangone.org for enrollment information.
Where is the NCT07909369 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07909369 clinical trial?
NCT07909369 is sponsored by NYU Langone Health. The principal investigator is Eric Strauss at NYU Langone Health. The trial plans to enroll 48 participants.